What is Xarelto Mobile App?
Xarelto Mobile App is a handy application that helps users keep track of their medication and appointments related to Xarelto, a popular anticoagulant drug. The app is available for free download on both Android and iOS devices, and it has several useful features that make it easier for patients to manage their treatment.
One of the primary functions of the Xarelto Mobile App is to allow patients to set reminders for when it's time to take their medication. Users can customize the frequency and dosage of their medication, and the app will send them notifications accordingly. This feature is particularly useful for individuals with a busy schedule or who tend to forget to take their medicine.
Another feature of the Xarelto Mobile App is its ability to track appointments and provide information about healthcare providers. Patients can use the app to keep a record of their appointments, set reminders, and access contact information for their doctors. This feature is especially convenient for those who see multiple healthcare providers or who have a lot of medical appointments to remember.
The Xarelto Mobile App also includes a medication tracker feature, which allows users to monitor their progress and track any side effects they might experience. This feature enables patients to keep an eye on their symptoms and report any concerns to their healthcare provider.
Overall, the Xarelto Mobile App is a fantastic tool for patients who take Xarelto. It helps them manage their medication, keep track of appointments, and communicate more effectively with their healthcare providers. With its user-friendly interface and range of useful features, the Xarelto Mobile App is a valuable asset for anyone looking to make their Xarelto treatment process more manageable.
Frequently Asked Questions about xarelto mobile app
Xarelto was invented in Bayer's Wuppertal laboratories in Germany, and is being jointly developed by Bayer HealthCare and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
XARELTO® is licensed from Bayer HealthCare AG, 51368 Leverkusen, Germany. Get additional support from Janssen CarePath to help you start and stay on therapy, visit JanssenCarePath.com,or call us.
XARELTO® is a prescription medicine used to: reduce the risk of stroke and blood clots in adults who have a medical condition called atrial fibrillation that is not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should.
- The active substance is rivaroxaban. Each tablet contains 15 mg or 20 mg of rivaroxaban.
- The other ingredients are: Tablet core: microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, hypromellose (2910), sodium laurilsulfate, magnesium stearate. See section 2 “Xarelto contains lactose and sodium”
History of Xarelto
Xarelto was first approved for marketing authorization in Canada in September 2008 to prevent venous thromboembolism (VTE) in people who have undergone elective total hip replacement or total knee replacement surgery.
Xarelto is only available as a brand-name drug. It doesn't come in a generic version. A generic drug is an exact copy of the active drug in a brand-name medication. Generics tend to cost less than brand-name drugs.
Bayer jointly developed Xarelto with J&J's Janssen Pharmaceuticals unit, which sells the blood clot preventer under a licensing agreement in the United States.
2.1% of patients treated with XARELTO® experienced another DVT vs 3.0% of patients treated with enoxaparin/vitamin K antagonist (EINSTEIN DVT). 2.1% of patients treated with XARELTO® experienced another PE vs 1.8% of patients treated with enoxaparin/vitamin K antagonist (EINSTEIN PE).
2.1% of patients treated with XARELTO® experienced another DVT vs 3.0% of patients treated with enoxaparin/vitamin K antagonist (EINSTEIN DVT). 2.1% of patients treated with XARELTO® experienced another PE vs 1.8% of patients treated with enoxaparin/vitamin K antagonist (EINSTEIN PE).
Rivaroxaban, also known as Xarelto®, is a prescribed anticoagulant medication (sometimes called a blood thinner). It's part of a class of medications called direct oral anticoagulants (DOACs).
Generic Name: rivaroxaban
In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure).
Rivaroxaban was initially developed by Bayer. In the United States, it is marketed by Janssen Pharmaceuticals (a part of Johnson & Johnson). It was the first available direct factor Xa inhibitor which is taken by mouth.
The cost for Xarelto oral tablet 20 mg is around $581 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
XARELTO® belongs to the category of blood thinners commonly called DOACs, or direct oral anticoagulants. One thing that makes DOACs different from older blood-thinning medications is that they affect fewer factors that help to form blood clots.
In 2008, rivaroxaban (Xarelto; Bayer HealthCare) became the first such compound to be approved for clinical use.
